Lotensin Hct Tablet
Product Images NDC 30698-454
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lotensin Hct (NDC 30698-454). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Validus Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Hydrochlorothiazide Structural Formula. (Lotensin Hct 02)
Principal Display Panel 10 mg Benazepril/12.5 mg Hydrochlorothiazide Tabletndc 30698-452-01lotensin Hct® Benazepril HCl Usp 10 mghydrochlorothiazide Usp 12.5 mg10/12.5 100 Tabletsrx Only (Lotensin Hct 03)
Principal Display Panel 20 mg Benazepril/12.5 mg Hydrochlorothiazide Tabletndc 30698-453-01lotensin Hct® 20/12.5benazepril HCl Usp 20 mghydrochlorothiazide Usp 12.5 mg20/12.5100 Tabletsrx Only (Lotensin Hct 04)
Principal Display Panel 20 mg Benazepril/25 mg Hydrochlorothiazide Tabletndc 30698-454-01lotensin Hct® 20/25benazepril HCl Usp 20 mghydrochlorothiazide Usp 25 mg20/25100 Tabletsrx Only (Lotensin Hct 05)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.